Cargando…
Re-Definition of the Epidemiology of Cardiac Amyloidosis
The epidemiology of cardiac amyloidosis (CA), traditionally considered a rare and incurable disease, has changed drastically over the last ten years, particularly due to the advances in diagnostic methods and therapeutic options in the field of transthyretin CA (ATTR-CA). On the one hand, the possib...
Autores principales: | Rossi, Maddalena, Varrà, Guerino Giuseppe, Porcari, Aldostefano, Saro, Riccardo, Pagura, Linda, Lalario, Andrea, Dore, Franca, Bussani, Rossana, Sinagra, Gianfranco, Merlo, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313045/ https://www.ncbi.nlm.nih.gov/pubmed/35884871 http://dx.doi.org/10.3390/biomedicines10071566 |
Ejemplares similares
-
Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination
por: Porcari, Aldostefano, et al.
Publicado: (2021) -
Light-chain cardiac amyloidosis: a case report of extraordinary
sustained pathological response to cyclophosphamide, bortezomib, and
dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation
por: Nuzzi, Vincenzo, et al.
Publicado: (2023) -
Cardiac amyloidosis: do not forget to look for it
por: Porcari, Aldostefano, et al.
Publicado: (2020)